T-cell acute lymphoblastic leukemia

Elizabeth A. Raetz(NYU Langone Health), David T. Teachey(Children's Hospital of Philadelphia)
Hematology
December 2, 2016
10.1182/asheducation-2016.1.580
Cited by 307

Related Papers

Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
|Leukemia|2008|581
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)
|Blood|2006|475